Central Composite Design-Optimized Dabigatran Etexilate Cubosomes for Sustained Oral Release and Enhanced In Vivo Pharmacokinetics.
- DOI
- 10.1007/s11095-026-04208-y
- Published
- 2026 Sep 24
- Container
- Pharmaceutical research
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s11095-026-04208-y,
title = {Central Composite Design-Optimized Dabigatran Etexilate Cubosomes for Sustained Oral Release and Enhanced In Vivo Pharmacokinetics.},
author = {Bhatt AH and Patel HP and Shaikh PS and Patel PR and Naik DK and Rathod HG and Vyas BA and Maulvi FA},
year = {2026},
journal = {Pharmaceutical research},
doi = {10.1007/s11095-026-04208-y},
url = {https://doi.org/10.1007/s11095-026-04208-y}
}RIS
TY - JOUR TI - Central Composite Design-Optimized Dabigatran Etexilate Cubosomes for Sustained Oral Release and Enhanced In Vivo Pharmacokinetics. AU - Bhatt AH AU - Patel HP AU - Shaikh PS AU - Patel PR AU - Naik DK AU - Rathod HG AU - Vyas BA AU - Maulvi FA PY - 2026 JO - Pharmaceutical research DO - 10.1007/s11095-026-04208-y UR - https://doi.org/10.1007/s11095-026-04208-y ER -
APA
AH, B., HP, P., PS, S., PR, P., DK, N., HG, R., BA, V., & FA, M. (2026). Central Composite Design-Optimized Dabigatran Etexilate Cubosomes for Sustained Oral Release and Enhanced In Vivo Pharmacokinetics.. Pharmaceutical research. https://doi.org/10.1007/s11095-026-04208-y
Source records
- pubmed · retrieved 2026-09-25T21:58:05.862Z